Correlation Engine 2.0
Clear Search sequence regions


  • b virus (20)
  • BCP (3)
  • dna viral (2)
  • gene (3)
  • gene viral (1)
  • genotypes (1)
  • hbeag (2)
  • human (3)
  • liver diseases (1)
  • patients (11)
  • risk factors (1)
  • Sizes of these terms reflect their relevance to your search.

    Human immunodeficiency virus (HIV)/hepatitis B virus (HBV) co-infection accelerates the progression of HBV-related liver diseases. HBV basic core promoter (BCP)/pre-core (preC) gene mutations may be one of the most important risk factors. In this study, a total of 230 patients were recruited, and 199 patients whose HBV BCP/preC gene were successfully amplified and sequenced, including 99 HIV/HBV co-infected and 100 HBV mono-infected patients. Next-generation sequencing was used for detection of BCP/preC mutations which were then compared in patients with different HBV genotypes and different HBeAg statuses, and 1% and 20% cutoff values were defined to evaluate the mutations. HBV quasispecies diversity was also compared in HIV/HBV co-infected and HBV mono-infected patients. Among the patients infected with HBV genotype C and HBeAg-negative status, the frequency of A1762T/G1764A double mutations was significantly lower in HIV/HBV co-infected patients than in HBV mono-infected patients (53.3% vs. 100.0%, P = 0.008) regardless of the 1% or 20% cutoff value level. However, A1762T/G1764A double mutations did not differ in the other groups (P >0.05). Viral quasispecies diversity was lower in HIV/HBV co-infected patients than in HBV mono-infected patients (P Keywords: human immunodeficiency virus, hepatitis B virus; mutations; viral quasispecies; next-generation sequencing.)

    Citation

    Haohui Deng, Hongbo Gao, Yu Liu, Ying Xu, Juncheng Yang, Miaoxian Zhao, Huiyuan Liu, Zhanhui Wang. Comparative analysis of HBV basic core promoter/pre-core gene mutations and viral quasispecies diversity in HIV/HBV co-infected and HBV mono-infected patients. Acta virologica. 2022;66(1):18-26

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 35380862

    View Full Text